HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nick Cammack Selected Research

2'-deoxy-2'-fluoro-2'-C-methylcytidine

12/2008Selected replicon variants with low-level in vitro resistance to the hepatitis C virus NS5B polymerase inhibitor PSI-6130 lack cross-resistance with R1479.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nick Cammack Research Topics

Disease

4Infections
02/2009 - 09/2006
2HIV Infections (HIV Infection)
05/2007 - 09/2004

Drug/Important Bio-Agent (IBA)

3Antiviral Agents (Antivirals)IBA
02/2009 - 05/2007
2NucleosidesIBA
01/2008 - 09/2004
12'-deoxy-2'-fluoro-2'-C-methylcytidineIBA
12/2008
14'-azidocytidineIBA
12/2008
12'- fluoro- 2'- methyl- 3',5'- diisobutyryldeoxycytidineIBA
12/2008
1ProdrugsIBA
12/2008
1Hexadimethrine BromideIBA
09/2006
1Protease Inhibitors (Protease Inhibitor)IBA
09/2004
1Reverse Transcriptase InhibitorsIBA
09/2004